Denise Mitchell
Adult Health · Seattle, WANPI 1609124031
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,309 of the $1,803 with a category attached, or 72.6%. It is spread thinly across 15 manufacturers, the largest accounting for just 19.1%.
Across 37 payments — averaging $48.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$344
- Beigene USA, Inc.$336
- E.r. Squibb & Sons, L.L.C.$275
- Incyte Corporation$146
- Blueprint Medicines Corporation$132
- Seagen Inc.$99
- plus $472 from 9 others
What the payments were for
- Food & beverage$1,30973%
- Education$49427%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 6 | $344 |
| Beigene USA, Inc. | 9 | $336 |
| E.r. Squibb & Sons, L.L.C. | 4 | $275 |
| Incyte Corporation | 2 | $146 |
| Blueprint Medicines Corporation | 1 | $132 |
| Seagen Inc. | 1 | $99 |
| Tempus AI, Inc | 1 | $92 |
| AstraZeneca | 4 | $79 |
| Johnson & Johnson | 1 | $74 |
| Daiichi Sankyo Inc. | 3 | $67 |
| Sobi, Inc | 1 | $50 |
| Pfizer | 1 | $42 |
| Amgen | 1 | $30 |
| Bristol Myers Squibb | 1 | $22 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,803 in reported general payments places this provider in the 85th percentile of 252 adult health providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 18 | $786 |
| Anastrozole | 18 | $303 |
| Acyclovir | 12 | $221 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $183 |
| Hydroxyurea | 14 | $164 |
| Prednisone | 13 | $104 |
Paid to pharmacies, not to this prescriber.
Other adult health in Seattle
- George BaxterSeattle$868K
- April WatkinsSeattle$101K
- Leslie SwansonSeattle$18K
- Kindra Clark-SnustadSeattle$10K
- Parminder MinhasSeattle$4K
- Zachary AnnenSeattle$4K
- Erika OrbanSeattle$3K
- Jessica LeibeltSeattle$3K
- Teresa Gegax-MartinezSeattle$2K
- Alvin AceronSeattle$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.